抗TNF治疗与炎症性肠病患者急性动脉事件风险:法国全国队列研究
与未暴露者相比,抗TNF暴露与急性动脉事件风险降低相关(HR 0.79,95%CI 0.66-0.95),而硫嘌呤暴露无显著关联(HR 0.93,95%CI 0.82-1.05)。风险降低幅度在男性克罗恩病患者中最大(HR 0.54,95%CI 0.40-0.72)。
要点
- 抗TNF暴露与IBD患者急性动脉事件风险降低相关(HR 0.79)。
- 硫嘌呤暴露与急性动脉事件风险无显著关联(HR 0.93)。
- 男性克罗恩病患者抗TNF暴露风险降低最显著(HR 0.54)。
核心结论
- 抗TNF暴露与IBD患者急性动脉事件风险降低相关,尤其在男性克罗恩病患者中。
主要发现
- 共发生4145例急性动脉事件,发病率为5.4/1000人年。
- 抗TNF暴露与急性动脉事件风险降低相关(HR 0.79,95%CI 0.66-0.95)。
- 硫嘌呤暴露与急性动脉事件风险无显著关联(HR 0.93,95%CI 0.82-1.05)。
- 男性克罗恩病患者抗TNF暴露风险降低幅度最大(HR 0.54,95%CI 0.40-0.72)。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patients with IBD are at increased risk of acute arterial events. Antitumour necrosis factor (TNF) agents and thiopurines may, via their anti-inflammatory properties, lower the risk of acute arterial events. The aim of this study was to assess the impact of thiopurines and anti-TNFs on the risk of acute arterial events in patients with IBD. DESIGN: Patients aged 18 years or older and affiliated to the French national health insurance with a diagnosis of IBD were followed up from 1 April 2010 until 31 December 2014. The risks of acute arterial events (including ischaemic heart disease, cerebrovascular disease and peripheral artery disease) were compared between thiopurines and anti-TNFs exposed and unexposed patients with marginal structural Cox proportional hazard models adjusting for baseline and time-varying demographics, medications, traditional cardiovascular risk factors, comorbidities and IBD disease activity. RESULTS: Among 177 827 patients with IBD (96 111 (54%) women, mean age at cohort entry 46.2 years (SD 16.3), 90 205 (50.7%) with Crohn's disease (CD)), 4145 incident acute arterial events occurred (incidence rates: 5.4 per 1000 person-years). Compared with unexposed patients, exposure to anti-TNFs (HR 0.79, 95% CI 0.66 to 0.95), but not to thiopurines (HR 0.93, 95% CI 0.82 to 1.05), was associated with a decreased risk of acute arterial events. The magnitude in risk reduction was highest in men with CD exposed to anti-TNFs (HR 0.54, 95% CI 0.40 to 0.72). CONCLUSION: Exposure to anti-TNFs is associated with a decreased risk of acute arterial events in patients with IBD, particularly in men with CD.
引用
- Kirchgesner J, Nyboe Andersen N, Carrat F, et al. Risk of acute arterial events associated with treatment of inflammatory bowel diseases: nationwide French cohort study. Gut. 2019. PMID: 31446428. doi:10.1136/gutjnl-2019-318932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。